Liu Yue, Tang Yanhui, Zhang Hui, Chen Hongying, Luo Qing, Liu Jinbo
Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Sichuan Province Engineering Technology Research Center of Molecular Diagnosis of Clinical Diseases, Luzhou, China.
Heliyon. 2024 Mar 27;10(7):e28677. doi: 10.1016/j.heliyon.2024.e28677. eCollection 2024 Apr 15.
Duchenne muscular dystrophy (DMD MIM#310200) is a degenerative muscle disease caused by mutations in the dystrophin gene located on Xp21.2. The clinical features encompass muscle weakness and markedly elevated serum creatine kinase levels. An 8-year-old Chinese boy was diagnosed with Duchenne muscular dystrophy (DMD). Whole exome gene sequencing was conducted and the Sanger method was used to validate sequencing. A deletion (c.5021del) in exon 35 of the dystrophin gene was identified, which was predicted to generate a frameshift mutation and create an early termination codon (p.Leu1674CysfsTer47). It has a pathogenic effect against dystrophin in the muscle cell membrane of the patient. As such, prednisone treatment at a dose of 0.75 mg/kg.d was administered. After one month, a notable reduction in fall frequency was observed. Our new finding will expand the pathogenic mutation spectrum causing DMD.
杜氏肌营养不良症(DMD,MIM#310200)是一种由位于Xp21.2的肌营养不良蛋白基因突变引起的退行性肌肉疾病。临床特征包括肌肉无力和血清肌酸激酶水平显著升高。一名8岁中国男孩被诊断为杜氏肌营养不良症(DMD)。进行了全外显子组基因测序,并使用桑格法验证测序结果。在肌营养不良蛋白基因第35外显子中鉴定出一个缺失(c.5021del),预计会产生移码突变并产生一个早期终止密码子(p.Leu1674CysfsTer47)。它对患者肌肉细胞膜中的肌营养不良蛋白具有致病作用。因此,给予了0.75mg/kg.d的泼尼松治疗。一个月后,观察到跌倒频率显著降低。我们的新发现将扩大导致DMD的致病突变谱。